Skip to main content

Year: 2021

Notification on the total number of voting rights granted by Linas Agro Group shares, the authorized capital amount, the number of shares and their nominal value

On 29 October 2021 during the Annual General Meeting of AB Linas Agro Group (hereinafter – “the Company“)  Shareholders, decision to increase Company’s authorised capital was taken. Security information after the increase of the share capital is as follows:Share type Ordinary registered sharesISIN LT0000128092Nominal, EUR 0.29Total number of shares 160,394,398Authorised capital of the Company, EUR 46,514,375.42Own shares acquired by the Company, EUR 767,972Number of votes, calculating the quorum of the General meeting of the shareholders* 159,626,426*All shares of the Company grant equal rights, though the shares acquired by the Company are considered to be non-voting shares in accordance with Paragraph 4 of Article 27 of the Law on Companies of the Republic of Lithuania. Additional information: Mažvydas Šileika,...

Continue reading

Reliq Health Technologies, Inc. Announces Contracts with Two New Clients in the US, Expansion of iUGO Platform for Hospice Care

HAMILTON, Ontario, Nov. 24, 2021 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global medtech company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed contracts with two new clients and has expanded the iUGO platform’s support for Hospice care by leveraging Reliq’s iUGO Care and iUGO Home modules. “We continue to grow our client base in the US and have added two new clients this week,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “These two contracts will add over 1,000 new Medicare patients to our platform at an average revenue of $65 USD per patient per month. Onboarding will begin next month. We are also very pleased to announce that we have...

Continue reading

Standard Lithium Announces US$100 Million Direct Investment From Koch Strategic Platforms

VANCOUVER, British Columbia, Nov. 24, 2021 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE: SLI) (FRA: S5L), an innovative technology and lithium project development company, today announced that Koch Strategic Platforms (“KSP”), a subsidiary of Koch Investments Group, will make a US$100 million investment in Standard Lithium through a direct private placement to support the Company’s strategic development goals. Key Points:US$100 million direct private placement (the “Direct Investment”); Standard Lithium to issue 13,480,083 common shares (“Common Shares”) of the Company at a price of CDN$9.43 (US$7.42) per Common Share; Direct Investment follows extensive due diligence into Standard Lithium’s LiSTR DLE technology, Demonstration Plant and project development objectives; and, Parties...

Continue reading

Futu Announces Third Quarter 2021 Unaudited Financial Results

HONG KONG, Nov. 24, 2021 (GLOBE NEWSWIRE) — Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform focusing on global investors, today announced its unaudited financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Operational HighlightsTotal number of paying clients1 increased 179.2% year-over-year to 1,167,204. Total number of registered clients2 increased 119.9% year-over-year to 2,580,002. Total number of users3 increased 58.6% year-over-year to 16.6 million. Total client assets increased 111.0% year-over-year to HK$423.9 billion. Daily average client assets were HK$444.1 billion in the third quarter of 2021, an increase of 146.3% from the same period in 2020. Total trading volume increased 33.1% year-over-year to HK$1.4...

Continue reading

PHILOGEN ANNOUNCES NEW COLLABORATION WITH JANSSEN TO DISCOVER SMALL MOLECULE THERAPEUTICS

PHILOGEN ANNOUNCES NEW COLLABORATION WITH JANSSEN TO DISCOVER SMALL MOLECULE THERAPEUTICS Siena, Italy, November 24, 2021 – Philogen S.p.A., a clinical-stage biotechnology company focused on antibody and small molecule-based targeted therapeutics, today announces that its wholly-owned Swiss subsidiary, Philochem AG, has entered into a new collaboration and option agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover new small molecules of pharmaceutical interest utilizing Philochem’s novel lead-generation technologies. The agreement was facilitated by Johnson & Johnson Innovation. Under the terms of the agreement, Philochem will work with Janssen to apply its proprietary DNA-encoded chemical library technology platform, seeking to identify small molecule compounds...

Continue reading

Interim financial report for 1 January – 30 September 2021 for FirstFarms A/S

CEO Anders H. Nørgaard.Satisfactory Q3 points to historic 2021 result The prices of crops have affected FirstFarms A/S’ result in the first 3 quarters of 2021 positively, as FirstFarms annually is a large net seller of crops. At the same time, FirstFarms has resisted the low pig prices, as this operation is one in four and therefore the company is not dependent on good prices for pigs. As a result, FirstFarms is presenting a satisfactory result in a very troubled market and announces that the company still expects a historically good result for 2021. The Board of Directors and Management of FirstFarms A/S have today reviewed and adopted the un-audited interim financial accounts for the period 1 January – 30 September 2021. FirstFarms has in the accounting period realised:A turnover of 248 mDKK An EBITDA of 74...

Continue reading

Casino Group: success of the debt refinancing transaction

Success of Casino Group debt refinancing transaction Paris, 24 November 2021, Casino Group announces the success of the debt refinancing transaction launched on 16 November 2021 composed of:A tap of its Term Loan B with maturity in August 2025 subject to the same terms and conditions (interest rate of Euribor1 + 4%) for an amount of €425 million, above the initial target of €400 million, at a price of 99,25% of the nominal amount. This tap increases the aggregate principal amount of the Term Loan B to €1,425 million; The buyback and cancellation of €105 million in aggregate principal amount of bonds maturing in January 2023 and March 2024, corresponding to the total amounts tendered.Notes Outstanding principal amount prior to the bond tender offer (€m) Aggregate principal amount purchased by Casino in the bond tender offer (€m) Outstanding...

Continue reading

Scatec’s Green Hydrogen Consortium in Egypt selects Plug Power for delivery of 100 MW Electrolyser

Oslo, November 24, 2021: Scatec (OSE: SCATC) and its partners, OCI NV, Fertiglobe (ADX: FERTIGLB), The Sovereign Fund of Egypt and Orascom Construction have selected Plug Power Inc. (NASDAQ: PLUG) as the technology provider of electrolyser for the 100 MW green hydrogen facility to be built at the Egyptian Basic Industries Corporation SAE (EBIC)’s facility in Ain Sokhna, Egypt. The hydrogen will be used to produce green ammonia. The 100 MW PEM (Polymer Electrolyte Membrane) electrolyser will be the largest globally when it comes online. Egypt is an ideal location to produce green hydrogen given its unique renewables profile with strong solar and wind loads, and proximity to markets with a hydrogen deficit. Green ammonia, produced from renewable energy such as solar and wind instead of natural gas, is a versatile product that is an ideal...

Continue reading

Irish Continental Group plc acquires ro-ro ferry Ciudad de Mahon

Irish Continental Group plc (ICG) is pleased to announce that it has entered into an agreement for the purchase of the passenger ro-ro ferry Ciudad de Mahon from Trasmed GLE. Title to the vessel will transfer to ICG on delivery which is expected by late January 2022. The vessel will serve the Dover – Calais route operated by Irish Ferries after dry docking and branding changes. The vessel was built in the year 2000 by Astilleros Espanoles S.A. (AESA), Spain. It has a gross tonnage of 22,152 tonne, passenger capacity of 589 and a freight unit carrying capacity of 91 units. The Company commenced services on the Dover – Calais route on 29 June 2021 with the Isle of Inishmore. The Isle of Innisfree (ex Calais Seaways) was delivered to the Group on 3 November 2021. She is currently undergoing drydocking and is expected to commence...

Continue reading

GOGL – Third Quarter 2021 Results

Golden Ocean Group Limited (NASDAQ: GOGL / OSE: GOGL) (the “Company” or “Golden Ocean”), the world’s largest listed owner of Capesize vessels, today announced its results for the quarter ended September 30, 2021. HighlightsNet income of $195.3 million and earnings per share of $0.97 for the third quarter of 2021 compared with net income of $104.5 million and earnings per share of $0.52 for the second quarter of 2021. Adjusted EBITDA of $229.7 million for the third quarter of 2021, compared with $130.5 million for the second quarter of 2021. Reported TCE rates for Capesize and Panamax/Ultramax vessels of $38,142 per day and $24,733 per day, respectively, in the third quarter of 2021. Reported TCE rate for the whole fleet of $32,262 per day. Entered into agreements to construct seven latest generation ECO-type Kamsarmax vessels. Sold...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.